Pharmacists Are On the Front Line of Women’s Health and Wellness
Drug Topics
AUGUST 15, 2023
Only 4% of money for research and development is used to focus on women’s health issues.
Tue.Aug 15, 2023
187 
Early Intervention With Nutrient Supplementation May Be Beneficial to Patients with Alzheimer Disease
Pharmacy Times
AUGUST 15, 2023
Through previous literature, investigators found that intervention with nutritional supplements may help to improve cognitive performance and reduce the severity of memory impairment in adults with Alzheimer disease.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Food Is Medicine: Pharmacists Can Advance Policies for Healthier Communities
Drug Topics
AUGUST 15, 2023
It's an exciting time for policies being made around food as medicine.
AI’s Shot in the Arm of Science and the Concerns We Need to Address
Pharmacy Times
AUGUST 15, 2023
Stakeholders need to convene honest, actionable discussions about the challenges and the safeguards needed to address appropriate use of artificial intelligence in health care.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
MorningRX: August 15, 2023
Drug Topics
AUGUST 15, 2023
Philips recall declared class I by the FDA, HHS launches civil rights investigation into Tennessee medical center, and experts warn about chemicals released into air and water during Maui wildfires.
Experts Create Guidelines for Management of Acetaminophen Poisoning
Pharmacy Times
AUGUST 15, 2023
A panel released recommendations in accordance with decades of a changing landscape in acetaminophen poisoning and due to an absence of agreed upon guidelines in the space.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Perioperative Gabapentinoids May Alleviate Pain, Reduce Opioid Use in Patients Undergoing Spine Surgery
Pharmacy Times
AUGUST 15, 2023
A dose of 900 mg per day of gabapentin prior to spine surgery was associated with the lowest pain score among all studied dosages.
Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to top of pharma's growth pack in Q2
Fierce Pharma
AUGUST 15, 2023
As the coronavirus surged and subsided, several biopharma companies experienced exaggerated revenue spikes and troughs. | Thanks to sales of their metabolism drugs, Novo Nordisk and Eli Lilly posted the biopharma industry’s largest revenue gains in the second quarter—by far. Meanwhile, only six of the industry’s top 20 firms experienced revenue decreases, with Pfizer's sales dropping a whopping 54%.
Pharmacy Can Help Drive Adoption of Rheumatoid Arthritis Biosimilars
Pharmacy Times
AUGUST 15, 2023
Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.
Patient advocates warn FDA proposal on salt intake could do fatal harm to people with kidney disease
STAT
AUGUST 15, 2023
WASHINGTON — Patient advocates are warning that a recent proposal from the Food and Drug Administration meant to reduce consumers’ salt intake could inadvertently kill those with kidney disease, particularly Black Americans. The proposal at issue, which is still in draft form , was unveiled by the FDA in April. It would allow the use of salt substitutes in foods that have so-called standards of identity, regulations governing what ingredients must go in popular foods, like ketchup,
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Common Cold Virus Associated With Rare Blood Clotting Disorder
Pharmacy Times
AUGUST 15, 2023
Prior to this study, anti-platelet factor 4 disorder was thought to be caused by exposure to heparin or autoimmune conditions.
STAT+: BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease
STAT
AUGUST 15, 2023
As Bristol Myers Squibb works to build its treatment for a heart condition that can cause difficulty breathing into a blockbuster drug, it’s propped up an algorithm designed to help find more people who are affected. The algorithm, called Viz HCM and developed by Viz.ai, earlier this month received clearance from the Food and Drug Administration.
Stada in 'exploratory talks' about possible sale, CEO says, but nothing is certain
Fierce Pharma
AUGUST 15, 2023
Speculation that Stada Arzneimittel may be looking for a buyout has largely been confirmed after the company’s CEO said as much in a recent German-language news story. | Responding to recent acquisition rumors, Stada Arzneimittel's CEO Peter Goldschmidt told the German Press Agency, “Whether and when STADA might be sold is solely the decision of our owners; Bain Capital and Cinven.
Radiation, a mainstay of cancer treatment, begins a fade-out
STAT
AUGUST 15, 2023
Every year, doctors get better tools to fight cancer. Engineered cancer-killing cells, immunotherapies, targeted drugs, and more are helping clinicians cure more patients. Increasingly, though, oncologists are trying to use less radiation, long one of the main pillars of cancer therapy. In some cases, they are even keeping certain patients with low-risk tumors off radiation entirely.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Hy-Vee opening infusion clinic in Chicago
Drug Store News
AUGUST 15, 2023
The infusion clinic will be referral-based and provide treatments for rheumatology, gastroenterology, pulmonary, neurology, dermatology, oncology and other chronic conditions.
STAT+: SEC wants to know if key supplier of research monkeys bribed foreign officials
STAT
AUGUST 15, 2023
A U.S. government probe into a monkey-smuggling operation emanating from Cambodia has gone in a new direction as the U.S. Securities and Exchange Commission examines whether Inotiv, a key importer, complied with a federal law that governs bribing foreign officials. The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importin
How Biogen outbid a rival 'large-cap' pharma to claim Reata for $7.3B
Fierce Pharma
AUGUST 15, 2023
Biogen’s $7.3 billion buyout of Skyclarys-maker Reata Pharmaceuticals surprised some industry watchers last month. | Biogen’s $7.3 billion buyout of Skyclarys-maker Reata Pharmaceuticals surprised some industry watchers last month. But it turns out Biogen wasn’t the only drugmaker jockeying for the Texas-based rare disease outfit, a new securities filing shows.
STAT+: From drug shortages to high prices, U.S. system’s shortcomings have deep roots
STAT
AUGUST 15, 2023
American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.
Hy-Vee opening infusion clinic in Chicago
Drug Store News
AUGUST 15, 2023
The infusion clinic will be referral-based and provide treatments for rheumatology, gastroenterology, pulmonary, neurology, dermatology, oncology and other chronic conditions.
Opinion: The best way for the NIH to reduce drug prices is to address drug spending
STAT
AUGUST 15, 2023
As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has indicated that it will not consider the nomination of Monica Bertagnolli as director of the National Institutes of Health unless she pledges to take specific steps to reduce drug prices. However, the HELP Committee may want to focus on reducing drug spending , the product of price and units prescribed, rather than simply pricing.
CMS unveils new changes to ACO REACH model
Fierce Healthcare
AUGUST 15, 2023
The Centers for Medicare & Medicaid Services (CMS) recently published new changes to further advance health equity and increase participation under the ACO REACH model. | New tweaks to the ACO REACH model, suggested by stakeholders and designed to encourage future participation, have generated a positive reception.
STAT+: FDA warns AstraZeneca over misleading promotional materials for a COPD drug
STAT
AUGUST 15, 2023
The Food and Drug Administration scolded AstraZeneca for making misleading claims about the effectiveness of a key medicine used treat chronic obstructive pulmonary disease. In an Aug. 4 warning letter , the agency admonished the company for a promotional sales aid that suggested the treatment, called Breztri, had a positive impact on death rates and reduced the risk of death in COPD patients.
Persistence pays for Delcath as cancer treatment Hepzato Kit finally scores FDA nod
Fierce Pharma
AUGUST 15, 2023
Almost a decade after Delcath suffered an FDA rejection for its drug/device combo, the company has crossed | Almost a decade after Delcath suffered an FDA rejection for its drug/device combo, the company has crossed the regulatory finish line in the U.S.
America’s ERs struggle with timely care for stroke patients
STAT
AUGUST 15, 2023
In the world of stroke care, time is everything. At stroke onset, a clot or ruptured blood vessel interrupts blood flow to the brain. Within minutes, brain cells starved of oxygen and nutrients begin to die. Every additional second that passes without blood flow increases the chance that the brain suffers irreparable damage, leading to permanent disability.
Beta-blocker use linked to higher CVD risk in patients with obstructive sleep apnoea
Hospital Pharmacy Europe
AUGUST 15, 2023
The use of beta-blockers is associated with an increased risk of cardiovascular disease (CVD) and a trend for a higher mortality risk among patients with obstructive sleep apnoea (OSA), according to the findings from a recent study. Researchers from University College London School of Pharmacy found that the use of beta-blocker drugs in patients with OSA increases the five-year risk of mortality and adverse cardiovascular outcomes.
YouTube cracks down on misinformation on cancer treatment
STAT
AUGUST 15, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Successful Drug Launches in a Digital-Forward Market: Q&A with Bridget Seay, Executive Director of Customer Experience & Commercial Consulting, epocrates
PharmExec
AUGUST 15, 2023
Bridget Seay of epocrates delves into drug launches in a digital-forward market, exploring how pharmaceutical companies can navigate complex patient journeys, strike a balance between traditional and digital marketing tactics, and ethically engage with healthcare professionals and empowered patients amidst ever-changing regulations.
MedArrive taps Heartbeat Health to connect Medicaid members with virtual cardiology care
Fierce Healthcare
AUGUST 15, 2023
Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the U.S. One person dies every 33 seconds in the U.S. | MedArrive is teaming up with Heartbeat Health to connect Medicaid members with virtual cardiology care in their homes.
Sandoz says its biosimilar matches Eylea in another threat to Regeneron's blockbuster
Fierce Pharma
AUGUST 15, 2023
With its blockbuster eye drug Eylea, Regeneron is already juggling between a recent FDA rejection and new competition. Meanwhile, biosimilar players are also eying a piece of the pie. | With its blockbuster eye drug Eylea, Regeneron is already juggling between a recent FDA rejection and new competition. Meanwhile, biosimilar players are also eying a piece of the pie.
Kinney Drugs receives CDM Certification from The Compliance Team
Drug Store News
AUGUST 15, 2023
Clinical Disease Management is a value-based care program that verifies and validates a pharmacy meets and/or exceeds the established standards for delivering disease management care.
No clear link between hospital market control and postoperative patient outcomes, study finds
Fierce Healthcare
AUGUST 15, 2023
Recent study data suggest hospitals in more competitive healthcare markets do not demonstrate clear post-surgery outcome improvements across several high-risk procedures—a thorn in the side of thos | A review of over 2.2 million Medicare claims across 10 different high-risk surgeries found mixed results when comparing hospitals in competitive and uncompetitive markets.
Perioperative pembrolizumab improves outcomes in early-stage NSCLC
Hospital Pharmacy Europe
AUGUST 15, 2023
A perioperative approach that includes both neoadjuvant and adjuvant immune checkpoint inhibition with pembrolizumab significantly improves disease outcomes for patients with early-stage non-small-cell lung cancer (NSCLC), according to the findings of a trial by an international research group. In recent years, immune checkpoint inhibitors such as pembrolizumab have transformed the management of NSCLC but whether both neoadjuvant and adjuvant immune checkpoint inhibition improves the clinical be
CPHI to return to Milan in 2024
European Pharmaceutical Review
AUGUST 15, 2023
CPHI, the global pharmaceutical event that spans the entire supply chain from ingredients and finished dosages to machinery, bio, and packaging will return to Fiera Milano (Rho) in 2024. The exhibition, which will take place from 8-10 October 2024, is being hosted in Milan for the second time in three years in recognition of the massive pharmaceutical ingredients and manufacturing industry in the region.
3 PioneerRx Features You Should Be Using
PioneerRx
AUGUST 15, 2023
The beauty of the independent pharmacy industry is how you can put your own unique spin on patient care. You’re helping patients your way, and your community is.
Let's personalize your content